BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34059134)

  • 1. Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches.
    Shakya S; Gromovsky AD; Hale JS; Knudsen AM; Prager B; Wallace LC; Penalva LOF; Brown HA; Kristensen BW; Rich JN; Lathia JD; Brown JM; Hubert CG
    Acta Neuropathol Commun; 2021 May; 9(1):101. PubMed ID: 34059134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
    Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
    EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells.
    Lathia JD; Gallagher J; Myers JT; Li M; Vasanji A; McLendon RE; Hjelmeland AB; Huang AY; Rich JN
    PLoS One; 2011; 6(9):e24807. PubMed ID: 21961046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.
    Ghosh D; Ulasov IV; Chen L; Harkins LE; Wallenborg K; Hothi P; Rostad S; Hood L; Cobbs CS
    Stem Cells; 2016 Sep; 34(9):2276-89. PubMed ID: 27354342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression.
    Hale JS; Otvos B; Sinyuk M; Alvarado AG; Hitomi M; Stoltz K; Wu Q; Flavahan W; Levison B; Johansen ML; Schmitt D; Neltner JM; Huang P; Ren B; Sloan AE; Silverstein RL; Gladson CL; DiDonato JA; Brown JM; McIntyre T; Hazen SL; Horbinski C; Rich JN; Lathia JD
    Stem Cells; 2014 Jul; 32(7):1746-58. PubMed ID: 24737733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
    Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
    Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Patient-Derived Glioblastoma with Cerebral Organoids.
    Linkous A; Balamatsias D; Snuderl M; Edwards L; Miyaguchi K; Milner T; Reich B; Cohen-Gould L; Storaska A; Nakayama Y; Schenkein E; Singhania R; Cirigliano S; Magdeldin T; Lin Y; Nanjangud G; Chadalavada K; Pisapia D; Liston C; Fine HA
    Cell Rep; 2019 Mar; 26(12):3203-3211.e5. PubMed ID: 30893594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomanufacturing of glioblastoma organoids exhibiting hierarchical and spatially organized tumor microenvironment via transdifferentiation.
    Park S; Avera AD; Kim Y
    Biotechnol Bioeng; 2022 Nov; 119(11):3252-3274. PubMed ID: 35869574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying conserved molecular targets required for cell migration of glioblastoma cancer stem cells.
    Volovetz J; Berezovsky AD; Alban T; Chen Y; Lauko A; Aranjuez GF; Burtscher A; Shibuya K; Silver DJ; Peterson J; Manor D; McDonald JA; Lathia JD
    Cell Death Dis; 2020 Feb; 11(2):152. PubMed ID: 32102991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells in glioblastoma.
    Lathia JD; Mack SC; Mulkearns-Hubert EE; Valentim CL; Rich JN
    Genes Dev; 2015 Jun; 29(12):1203-17. PubMed ID: 26109046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cell hypothesis 2.0 in glioblastoma: Where are we now and where are we going?
    Sloan AR; Silver DJ; Kint S; Gallo M; Lathia JD
    Neuro Oncol; 2024 May; 26(5):785-795. PubMed ID: 38394444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids.
    Pinto G; Saenz-de-Santa-Maria I; Chastagner P; Perthame E; Delmas C; Toulas C; Moyal-Jonathan-Cohen E; Brou C; Zurzolo C
    Biochem J; 2021 Jan; 478(1):21-39. PubMed ID: 33245115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-mediated cancer stem cells in pseudopalisades with activation of hypoxia-inducible factor-1α/Akt axis in glioblastoma.
    Inukai M; Hara A; Yasui Y; Kumabe T; Matsumoto T; Saegusa M
    Hum Pathol; 2015 Oct; 46(10):1496-505. PubMed ID: 26256949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).
    Bryukhovetskiy I; Ponomarenko A; Lyakhova I; Zaitsev S; Zayats Y; Korneyko M; Eliseikina M; Mischenko P; Shevchenko V; Shanker Sharma H; Sharma A; Khotimchenko Y
    Int J Mol Med; 2018 Aug; 42(2):691-702. PubMed ID: 29749540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma.
    Tafani M; Di Vito M; Frati A; Pellegrini L; De Santis E; Sette G; Eramo A; Sale P; Mari E; Santoro A; Raco A; Salvati M; De Maria R; Russo MA
    J Neuroinflammation; 2011 Apr; 8():32. PubMed ID: 21489226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
    Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
    Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype.
    Liu YC; Lee IC; Chen PY
    J Neurooncol; 2018 May; 137(3):511-522. PubMed ID: 29357090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer.
    Hassn Mesrati M; Behrooz AB; Y Abuhamad A; Syahir A
    Cells; 2020 May; 9(5):. PubMed ID: 32429463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation.
    Berezovsky AD; Poisson LM; Cherba D; Webb CP; Transou AD; Lemke NW; Hong X; Hasselbach LA; Irtenkauf SM; Mikkelsen T; deCarvalho AC
    Neoplasia; 2014 Mar; 16(3):193-206, 206.e19-25. PubMed ID: 24726753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marker-independent method for isolating slow-dividing cancer stem cells in human glioblastoma.
    Richichi C; Brescia P; Alberizzi V; Fornasari L; Pelicci G
    Neoplasia; 2013 Jul; 15(7):840-7. PubMed ID: 23814495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.